JP2010540446A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010540446A5 JP2010540446A5 JP2010525937A JP2010525937A JP2010540446A5 JP 2010540446 A5 JP2010540446 A5 JP 2010540446A5 JP 2010525937 A JP2010525937 A JP 2010525937A JP 2010525937 A JP2010525937 A JP 2010525937A JP 2010540446 A5 JP2010540446 A5 JP 2010540446A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- decrease
- composition according
- caused
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 18
- 230000035945 sensitivity Effects 0.000 claims 10
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 claims 7
- 108010036949 Cyclosporine Proteins 0.000 claims 7
- 229960001265 ciclosporin Drugs 0.000 claims 6
- 229930105110 Cyclosporin A Natural products 0.000 claims 5
- 208000036142 Viral infection Diseases 0.000 claims 5
- 230000009385 viral infection Effects 0.000 claims 5
- 238000001356 surgical procedure Methods 0.000 claims 3
- 108010013381 Porins Proteins 0.000 claims 2
- 229930182912 cyclosporin Natural products 0.000 claims 2
- 102000007739 porin activity proteins Human genes 0.000 claims 2
- 206010061788 Corneal infection Diseases 0.000 claims 1
- 241000700588 Human alphaherpesvirus 1 Species 0.000 claims 1
- 241000701074 Human alphaherpesvirus 2 Species 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 210000004087 cornea Anatomy 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000003755 preservative agent Substances 0.000 claims 1
- 230000002335 preservative effect Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/858,200 US20080146497A1 (en) | 2006-07-25 | 2007-09-20 | Cyclosporin Compositions |
| PCT/US2008/076756 WO2009099467A2 (en) | 2007-09-20 | 2008-09-18 | Cyclosporin compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010540446A JP2010540446A (ja) | 2010-12-24 |
| JP2010540446A5 true JP2010540446A5 (https=) | 2011-11-10 |
Family
ID=39528114
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010525937A Pending JP2010540446A (ja) | 2007-09-20 | 2008-09-18 | シクロスポリン組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20080146497A1 (https=) |
| EP (1) | EP2190407B1 (https=) |
| JP (1) | JP2010540446A (https=) |
| KR (1) | KR20100091946A (https=) |
| CN (1) | CN101835463A (https=) |
| AU (1) | AU2008349774A1 (https=) |
| BR (1) | BRPI0816995A2 (https=) |
| CA (1) | CA2700182A1 (https=) |
| IL (1) | IL204614A0 (https=) |
| MX (1) | MX2010003045A (https=) |
| RU (1) | RU2010112472A (https=) |
| WO (1) | WO2009099467A2 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050059583A1 (en) | 2003-09-15 | 2005-03-17 | Allergan, Inc. | Methods of providing therapeutic effects using cyclosporin components |
| ES2667945T3 (es) | 2007-10-08 | 2018-05-16 | Aurinia Pharmaceuticals Inc. | Composiciones oftálmicas que comprenden inhibidores de calcineurina o Inhibidores de mTOR |
| WO2010127301A1 (en) * | 2009-05-01 | 2010-11-04 | Allergan, Inc. | Method of treating allergic conjunctivitis with cyclosporin compositions |
| EP2440185B1 (en) * | 2009-06-09 | 2015-04-08 | Aurinia Pharmaceuticals Inc. | Topical drug delivery systems for ophthalmic use |
| AU2012351948A1 (en) * | 2011-12-16 | 2014-07-10 | Allergan, Inc. | Ophthalmic compositions comprising polyvinyl capralactam - polyvinyl acetate - polyethylene glycol graft copolymer |
| FR2988297B1 (fr) * | 2012-03-22 | 2014-03-28 | Thea Lab | Solution ophtalmique aqueuse a base de ciclosporine a sans conservateur |
| JP2015519368A (ja) | 2012-06-01 | 2015-07-09 | アラーガン インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ | シクロスポリンａ類似体 |
| RU2713953C2 (ru) * | 2014-07-18 | 2020-02-11 | Аллерган, Инк. | Суспензионные составы циклоспорина а для субконъюнктивального и периокулярного введения |
| KR101587412B1 (ko) * | 2014-10-17 | 2016-01-21 | 주식회사 휴온스 | 사이클로스포린 및 트레할로스를 포함하는 안과용 조성물 |
| US9914755B2 (en) | 2015-01-08 | 2018-03-13 | Allergan, Inc. | Cyclosporin derivatives wherein the MeBmt sidechain has been cyclized |
| US20190224275A1 (en) | 2017-05-12 | 2019-07-25 | Aurinia Pharmaceuticals Inc. | Protocol for treatment of lupus nephritis |
| RU2762767C1 (ru) * | 2020-09-15 | 2021-12-22 | Федеральное государственное автономное учреждение "Национальный медицинский исследовательский центр "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Министерства здравоохранения Российской Федерации | Способ определения тактильной чувствительности роговицы |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2577049B2 (ja) * | 1987-06-04 | 1997-01-29 | 三共株式会社 | シクロスポリン製剤 |
| KR920003601B1 (ko) * | 1987-09-03 | 1992-05-04 | 유니버시티 어브 죠지아 리서취 화운데이션 인코포레이티드 | 점안 싸이클로스포린(cyclosporin)의 조성물 |
| HK1004520A1 (en) * | 1992-05-13 | 1998-11-27 | Novartis Ag | Ophthalmic compositions containing a cyclosporin |
| DK2153819T3 (da) * | 2000-07-14 | 2012-12-03 | Allergan Inc | Anvendelse af en opløselighedsforbedrende bestanddel i en vandig sammensætning omfattende brimonidintartrat |
| EP1904056B1 (en) * | 2005-07-18 | 2009-04-29 | Minu, L.L.C. | Use of a macrolide to restore corneal sensation |
| US7501393B2 (en) * | 2005-07-27 | 2009-03-10 | Allergan, Inc. | Pharmaceutical compositions comprising cyclosporins |
| JP2009514969A (ja) * | 2005-11-09 | 2009-04-09 | コンビナトアールエックス インコーポレーティッド | 医学的状態を治療するための方法、組成物、およびキット |
-
2007
- 2007-09-20 US US11/858,200 patent/US20080146497A1/en not_active Abandoned
-
2008
- 2008-09-18 WO PCT/US2008/076756 patent/WO2009099467A2/en not_active Ceased
- 2008-09-18 RU RU2010112472/15A patent/RU2010112472A/ru not_active Application Discontinuation
- 2008-09-18 AU AU2008349774A patent/AU2008349774A1/en not_active Abandoned
- 2008-09-18 BR BRPI0816995 patent/BRPI0816995A2/pt not_active IP Right Cessation
- 2008-09-18 CA CA2700182A patent/CA2700182A1/en not_active Abandoned
- 2008-09-18 CN CN200880113223A patent/CN101835463A/zh active Pending
- 2008-09-18 EP EP08872212.9A patent/EP2190407B1/en not_active Not-in-force
- 2008-09-18 JP JP2010525937A patent/JP2010540446A/ja active Pending
- 2008-09-18 MX MX2010003045A patent/MX2010003045A/es not_active Application Discontinuation
- 2008-09-18 KR KR1020107008509A patent/KR20100091946A/ko not_active Withdrawn
-
2010
- 2010-03-18 IL IL204614A patent/IL204614A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010540446A5 (https=) | ||
| Zhu et al. | Broad-spectrum antiviral agents | |
| RU2010112472A (ru) | Композиции циклоспорина | |
| Burka et al. | The effect of fourth-generation fluoroquinolones gatifloxacin and moxifloxacin on epithelial healing following photorefractive keratectomy | |
| JP2020502197A5 (https=) | ||
| JP2014516954A5 (https=) | ||
| RU2012140704A (ru) | Способ профилактики и/или лечения фиброза и/или помутнения роговицы (варианты), способ получения фармацевтической композиции для профилактики и/или лечения фиброза и/или помутнения роговицы и глазная фармацевтическая композиция | |
| RU2010141542A (ru) | Низковязкие высокофлокулированные суспензии триамцинолона ацетонида для интравитреальных инъекций | |
| JP2013542224A5 (https=) | ||
| CN102066402B (zh) | 肽衍生物以及含有肽衍生物的用于促进泪液分泌的组合物 | |
| KR20090008291A (ko) | 눈꺼풀, 눈 표면, 피부 또는 귀에 감염 또는 감염성 정착 치료를 위한 조성물 및 방법 | |
| RU2017118405A (ru) | Новое лечение роговицы с применением ламинина | |
| CN116211890A (zh) | 二维纳米材料在抑制冠状病毒的应用 | |
| Jose et al. | A cationic peptide, TAT-Cd0, inhibits herpes simplex virus type 1 ocular infection in vivo | |
| KR20180037185A (ko) | 광범위의 항감염성 펩티드 | |
| JP5686454B1 (ja) | コンタクトレンズ装着用液剤およびそれを用いたコンタクトレンズの屈折率向上方法 | |
| JP2018536638A5 (https=) | ||
| CN104147162B (zh) | 风湿止痛液及其使用方法 | |
| CN108815141A (zh) | 抗菌肽膜剂及其制备方法与应用 | |
| RU2008102249A (ru) | Профилактический или терапевтичесский агент для корнеального /конъюнктивального заболевания | |
| KR20110104367A (ko) | 무보존제 안과용 조성물 | |
| CA3145062C (en) | COMPOSITIONS AND METHODS OF TREATMENT OR PREVENTION OF EYE INFECTIONS WITH FILOCICLOVIR | |
| Daelemans et al. | Debio-025 inhibits HIV-1 by interfering with an early event in the replication cycle | |
| JP2019525923A5 (https=) | ||
| Bravo et al. | A model of human cytomegalovirus infection in severe combined immunodeficient mice |